SEC Tracker
Get the app
TMO · XBRL financial data

Thermo Fisher Scientific financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (TMO's year ends in late December)

In millions of dollarsDec 31, 2023Mar 30, 2024Jun 29, 2024Sep 28, 2024Dec 31, 2024Mar 29, 2025Jun 28, 2025Sep 27, 2025Dec 31, 2025Mar 28, 2026Jun 27, 2026Sep 26, 2026
Revenue from contracts with customers10,886*10,34510,54110,59811,395*10,36410,85511,12212,215*11,00511,99412,137
Research and development327*331339346374*342352346356*336364348
Selling, general and administrative2,132*2,1832,1112,0982,203*2,0782,1402,1622,352*2,1812,3332,321
Operating income (loss)1,854*1,6631,8201,8382,016*1,7161,8341,9412,255*1,8632,0872,263
Interest income309*279295277227*203297234258*233207*252
Interest expense390*363354356317*303404347365*354401*417
Other income (expense)(33)*105(16)14*3(19)(2)6*(9)31*(10)
Income tax expense (benefit)133*28112899150*9592207153*70167352
Net income (loss)year only—1,5481,6301,830*1,5071,6171,6161,964*1,6511,7361,721
Earnings per share, basic USD per share—3.474.054.26—3.994.284.285.25*4.444.684.65
Earnings per share, diluted USD per share—3.464.044.25—3.984.284.275.21*4.434.684.64
Weighted average shares, basic millions of shares386*382382382382*378378378374*372371370
Weighted average shares, diluted millions of shares388*384383384381*379378378377*373371371

Balance sheet

CSV

Fiscal quarters (TMO's year ends in late December)

In millions of dollarsDec 31, 2023Mar 30, 2024Jun 29, 2024Sep 28, 2024Dec 31, 2024Mar 29, 2025Jun 28, 2025Sep 27, 2025Dec 31, 2025Mar 28, 2026Jun 27, 2026Sep 26, 2026
Cash and cash equivalents8,0775,4997,0734,6454,0094,1344,5761,9829,8523,2544,0645,461
Short-term investments31,7511,7502,0001,5611,8131,8141,56425320600
Accounts receivable8,2217,9317,9438,2558,1918,4558,5948,9118,9009,2049,4519,625
Inventory5,0885,1335,1985,4304,9785,2245,5595,7455,4255,4965,6275,643
Total current assets24,58923,64025,47623,78322,13723,37824,58422,29528,70722,31623,36525,615
Property and equipment, net9,4489,3249,2829,4129,3069,3319,63510,17710,56510,65810,75510,577
Right-of-use asset1,556———1,489———1,447———
Goodwill44,02043,84343,84346,72645,85346,49347,24949,28749,36255,18754,83254,263
Total assets98,72697,09598,496100,36497,32199,041101,230103,020110,343113,281113,174114,233
Accounts payable2,8722,5552,5472,6063,0793,0492,9803,1203,6223,3443,2683,087
Total current liabilities14,01213,93714,77214,60113,33213,17412,71814,88815,18914,62115,06914,170
Lease liability, non-current1,244———1,239———1,195———
Retained earnings47,36448,54249,94051,42153,10254,44755,90157,35459,15660,63262,19463,740
Total stockholders' equity46,73545,51647,43248,99249,58449,39050,51251,01853,40751,93452,67954,761
Total liabilities and equity98,72697,09598,496100,36497,32199,041101,230103,020110,343113,281113,174114,233
Common shares outstanding (cover page) millions of shares381382382383377377378376371372370371

Cash flows

CSV

Fiscal quarters (TMO's year ends in late December)

In millions of dollarsDec 31, 2023Mar 30, 2024Jun 29, 2024Sep 28, 2024Dec 31, 2024Mar 29, 2025Jun 28, 2025Sep 27, 2025Dec 31, 2025Mar 28, 2026Jun 27, 2026Sep 26, 2026
Net income (loss)year only—1,5481,6301,830*1,5071,6171,6161,964*1,6511,7361,721
Stock-based compensation61*7084*68*79*7581*70*84*8382*96*
Net cash from operating activities3,723*1,2511,960*2,166*3,290*7231,399*2,239*3,457*1,1922,125*2,550*
Purchases of property and equipment405*347301*272*480*362294*404*465*376450*437*
Net cash from investing activities(376)*(2,030)(253)*(3,578)*20*(527)(288)*(4,123)*891*(8,961)164*(77)*
Share repurchases0*3,0000*0*1,000*2,0000*963*37*3,0001,000*0*
Dividends paid136*135149*150*149*149162*163*162*162175*174*
Proceeds from long-term debt2,476*1,205(1)*0*0*2,8400*0*4,919*5,2380*0*
Repayments of long-term debt3,782*00*1,107*2,500*838787*0*787*1,4120*1,107*
Net cash from financing activities(1,428)*(1,821)(115)*(1,190)*(3,666)*(102)(991)*(632)*3,526*1,093(1,571)*(1,063)*
Net change in cash1,929*(2,578)1,578*(2,427)*(630)*132431*(2,592)*7,868*(6,599)817*1,398*

Compare with peers

SIC 3829 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3829 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingQuarter
Thermo Fisher Scientific5,46112,1372,550*370.5M 10-QSep 26, 2026
KLA1,5324,1361,5311.3B 10-QSep 30, 2026
Danaher5,6826,5541,886*703.5M 10-QSep 25, 2026
Trane Technologiesnot reported6,7601,313*218.9M 10-QSep 30, 2026
Roper Technologies3112,172821*99.0M 10-QSep 30, 2026
Ametek6662,220561*229.3M 10-QSep 30, 2026
Coherent1,1622,046*69*195.8M 10-KJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.